Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 529 to 537 of 537 entries
Sorted by: Best Match Show Resources per page
Physiologically activated phase transition systems for improved ocular retention of ketorolac tromethamine.

Journal of pharmacy & bioallied sciences

Thakor S, Vhora I, Desai J, Thakkar S, Thakkar H.
PMID: 23066208
J Pharm Bioallied Sci. 2012 Mar;4:S6-7. doi: 10.4103/0975-7406.94117.

In present investigation, novel physiologically activated phase transition systems for Ketorolac Tromethamine was developed. In-situ gelling systems: pH sensitive gel using carbopol 980 and HPMC K100LV, ion sensitive gel using gallan gum and temperature sensitive gel using Poloxamer 407...

Cite
Thakor S, Vhora I, Desai J, et al. Physiologically activated phase transition systems for improved ocular retention of ketorolac tromethamine. J Pharm Bioallied Sci. 2012;4:S6-7doi: 10.4103/0975-7406.94117.
Thakor, S., Vhora, I., Desai, J., Thakkar, S., & Thakkar, H. (2012). Physiologically activated phase transition systems for improved ocular retention of ketorolac tromethamine. Journal of pharmacy & bioallied sciences, 4S6-7. https://doi.org/10.4103/0975-7406.94117
Thakor, Sunil, et al. "Physiologically activated phase transition systems for improved ocular retention of ketorolac tromethamine." Journal of pharmacy & bioallied sciences vol. 4 (2012): S6-7. doi: https://doi.org/10.4103/0975-7406.94117
Thakor S, Vhora I, Desai J, Thakkar S, Thakkar H. Physiologically activated phase transition systems for improved ocular retention of ketorolac tromethamine. J Pharm Bioallied Sci. 2012 Mar;4:S6-7. doi: 10.4103/0975-7406.94117. PMID: 23066208; PMCID: PMC3467811.
Copy Download .nbib Format: NLM
Tau pathology mediates age effects on medial temporal lobe structure.

Neurobiology of aging

Wisse LE, Xie L, Das SR, de Flores R, Hansson O, Habes M, Doshi J, Davatzikos C, Yushkevich PA, Wolk DA.
PMID: 34740075
Neurobiol Aging. 2022 Jan;109:135-144. doi: 10.1016/j.neurobiolaging.2021.09.017. Epub 2021 Sep 24.

Hippocampal atrophy is endemic in 'normal aging' but it is unclear what factors drive age-related changes in medial temporal lobe (MTL) structural measures. We investigated cross-sectional (n = 191) and longitudinal (n = 164) MTL atrophy patterns in cognitively...

Cite
Wisse LE, Xie L, Das SR, et al. Tau pathology mediates age effects on medial temporal lobe structure. Neurobiol Aging. 2021;109:135-144doi: 10.1016/j.neurobiolaging.2021.09.017.
Wisse, L. E., Xie, L., Das, S. R., de Flores, R., Hansson, O., Habes, M., Doshi, J., Davatzikos, C., Yushkevich, P. A., Wolk, D. A. (2022). Tau pathology mediates age effects on medial temporal lobe structure. Neurobiology of aging, 109135-144. https://doi.org/10.1016/j.neurobiolaging.2021.09.017
Wisse, Laura Em, et al. "Tau pathology mediates age effects on medial temporal lobe structure." Neurobiology of aging vol. 109 (2022): 135-144. doi: https://doi.org/10.1016/j.neurobiolaging.2021.09.017
Wisse LE, Xie L, Das SR, de Flores R, Hansson O, Habes M, Doshi J, Davatzikos C, Yushkevich PA, Wolk DA. Tau pathology mediates age effects on medial temporal lobe structure. Neurobiol Aging. 2022 Jan;109:135-144. doi: 10.1016/j.neurobiolaging.2021.09.017. Epub 2021 Sep 24. PMID: 34740075.
Copy Download .nbib Format: NLM
The Pediatric Neurology Trainee Publication Award.

Pediatric neurology

Khakoo Y, Brenton JN, Brumback AC, Desai J, Mytinger JR, Reese JJ, Scantlebury MH.
PMID: 34411953
Pediatr Neurol. 2021 Oct;123:85. doi: 10.1016/j.pediatrneurol.2021.07.014. Epub 2021 Jul 29.

No abstract available.

Cite
Khakoo Y, Brenton JN, Brumback AC, et al. The Pediatric Neurology Trainee Publication Award. Pediatr Neurol. 2021;123:85doi: 10.1016/j.pediatrneurol.2021.07.014.
Khakoo, Y., Brenton, J. N., Brumback, A. C., Desai, J., Mytinger, J. R., Reese, J. J., & Scantlebury, M. H. (2021). The Pediatric Neurology Trainee Publication Award. Pediatric neurology, 12385. https://doi.org/10.1016/j.pediatrneurol.2021.07.014
Khakoo, Yasmin, et al. "The Pediatric Neurology Trainee Publication Award." Pediatric neurology vol. 123 (2021): 85. doi: https://doi.org/10.1016/j.pediatrneurol.2021.07.014
Khakoo Y, Brenton JN, Brumback AC, Desai J, Mytinger JR, Reese JJ, Scantlebury MH. The Pediatric Neurology Trainee Publication Award. Pediatr Neurol. 2021 Oct;123:85. doi: 10.1016/j.pediatrneurol.2021.07.014. Epub 2021 Jul 29. PMID: 34411953.
Copy Download .nbib Format: NLM
Gastrointestinal pathophysiology of SARS-CoV2 - a literature review.

Journal of community hospital internal medicine perspectives

Syed A, Khan A, Gosai F, Asif A, Dhillon S.
PMID: 33194122
J Community Hosp Intern Med Perspect. 2020 Oct 29;10(6):523-528. doi: 10.1080/20009666.2020.1811556.

SARS-CoV2 is a novel coronavirus responsible for causing COVID-19, first identified in the city of Wuhan, China and officially declared a pandemic by the World Health Organization. SARS-CoV2 expresses high affinity to human ACE2 receptors, including within the gastrointestinal...

Cite
Syed A, Khan A, Gosai F, et al. Gastrointestinal pathophysiology of SARS-CoV2 - a literature review. J Community Hosp Intern Med Perspect. 2020;10(6):523-528doi: 10.1080/20009666.2020.1811556.
Syed, A., Khan, A., Gosai, F., Asif, A., & Dhillon, S. (2020). Gastrointestinal pathophysiology of SARS-CoV2 - a literature review. Journal of community hospital internal medicine perspectives, 10(6), 523-528. https://doi.org/10.1080/20009666.2020.1811556
Syed, Anwaruddin, et al. "Gastrointestinal pathophysiology of SARS-CoV2 - a literature review." Journal of community hospital internal medicine perspectives vol. 10,6 (2020): 523-528. doi: https://doi.org/10.1080/20009666.2020.1811556
Syed A, Khan A, Gosai F, Asif A, Dhillon S. Gastrointestinal pathophysiology of SARS-CoV2 - a literature review. J Community Hosp Intern Med Perspect. 2020 Oct 29;10(6):523-528. doi: 10.1080/20009666.2020.1811556. PMID: 33194122; PMCID: PMC7599006.
Copy Download .nbib Format: NLM
Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.

The Journal of experimental medicine

Li J, Lei WT, Zhang P, Rapaport F, Seeleuthner Y, Lyu B, Asano T, Rosain J, Hammadi B, Zhang Y, Pelham SJ, Spaan AN, Migaud M, Hum D, Bigio B, Chrabieh M, Béziat V, Bustamante J, Zhang SY, Jouanguy E, Boisson-Dupuis S, El Baghdadi J, Aimanianda V, Thoma K, Fliegauf M, Grimbacher B, Korganow AS, Saunders C, Rao VK, Uzel G, Freeman AF, Holland SM, Su HC, Cunningham-Rundles C, Fieschi C, Abel L, Puel A, Cobat A, Casanova JL, Zhang Q, Boisson B.
PMID: 34473196
J Exp Med. 2021 Nov 01;218(11). doi: 10.1084/jem.20210566. Epub 2021 Sep 02.

Autosomal dominant (AD) NFKB1 deficiency is thought to be the most common genetic etiology of common variable immunodeficiency (CVID). However, the causal link between NFKB1 variants and CVID has not been demonstrated experimentally and genetically, and there has been...

Cite
Li J, Lei WT, Zhang P, et al. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency. J Exp Med. 2021;218(11)doi: 10.1084/jem.20210566.
Li, J., Lei, W. T., Zhang, P., Rapaport, F., Seeleuthner, Y., Lyu, B., Asano, T., Rosain, J., Hammadi, B., Zhang, Y., Pelham, S. J., Spaan, A. N., Migaud, M., Hum, D., Bigio, B., Chrabieh, M., Béziat, V., Bustamante, J., Zhang, S. Y., Jouanguy, E., Boisson-Dupuis, S., El Baghdadi, J., Aimanianda, V., Thoma, K., Fliegauf, M., Grimbacher, B., Korganow, A. S., Saunders, C., Rao, V. K., Uzel, G., Freeman, A. F., Holland, S. M., Su, H. C., Cunningham-Rundles, C., Fieschi, C., Abel, L., Puel, A., Cobat, A., Casanova, J. L., Zhang, Q., & Boisson, B. (2021). Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency. The Journal of experimental medicine, 218(11), . https://doi.org/10.1084/jem.20210566
Li, Juan, et al. "Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency." The Journal of experimental medicine vol. 218,11 (2021). doi: https://doi.org/10.1084/jem.20210566
Li J, Lei WT, Zhang P, Rapaport F, Seeleuthner Y, Lyu B, Asano T, Rosain J, Hammadi B, Zhang Y, Pelham SJ, Spaan AN, Migaud M, Hum D, Bigio B, Chrabieh M, Béziat V, Bustamante J, Zhang SY, Jouanguy E, Boisson-Dupuis S, El Baghdadi J, Aimanianda V, Thoma K, Fliegauf M, Grimbacher B, Korganow AS, Saunders C, Rao VK, Uzel G, Freeman AF, Holland SM, Su HC, Cunningham-Rundles C, Fieschi C, Abel L, Puel A, Cobat A, Casanova JL, Zhang Q, Boisson B. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency. J Exp Med. 2021 Nov 01;218(11). doi: 10.1084/jem.20210566. Epub 2021 Sep 02. PMID: 34473196; PMCID: PMC8421261.
Copy Download .nbib Format: NLM
The pink salmon genome: Uncovering the genomic consequences of a two-year life cycle.

PloS one

Christensen KA, Rondeau EB, Sakhrani D, Biagi CA, Johnson H, Joshi J, Flores AM, Leelakumari S, Moore R, Pandoh PK, Withler RE, Beacham TD, Leggatt RA, Tarpey CM, Seeb LW, Seeb JE, Jones SJM, Devlin RH, Koop BF.
PMID: 34919547
PLoS One. 2021 Dec 17;16(12):e0255752. doi: 10.1371/journal.pone.0255752. eCollection 2021.

Pink salmon (Oncorhynchus gorbuscha) adults are the smallest of the five Pacific salmon native to the western Pacific Ocean. Pink salmon are also the most abundant of these species and account for a large proportion of the commercial value...

Cite
Christensen KA, Rondeau EB, Sakhrani D, et al. The pink salmon genome: Uncovering the genomic consequences of a two-year life cycle. PLoS One. 2021;16(12):e0255752doi: 10.1371/journal.pone.0255752.
Christensen, K. A., Rondeau, E. B., Sakhrani, D., Biagi, C. A., Johnson, H., Joshi, J., Flores, A. M., Leelakumari, S., Moore, R., Pandoh, P. K., Withler, R. E., Beacham, T. D., Leggatt, R. A., Tarpey, C. M., Seeb, L. W., Seeb, J. E., Jones, S. J. M., Devlin, R. H., & Koop, B. F. (2021). The pink salmon genome: Uncovering the genomic consequences of a two-year life cycle. PloS one, 16(12), e0255752. https://doi.org/10.1371/journal.pone.0255752
Christensen, Kris A, et al. "The pink salmon genome: Uncovering the genomic consequences of a two-year life cycle." PloS one vol. 16,12 (2021): e0255752. doi: https://doi.org/10.1371/journal.pone.0255752
Christensen KA, Rondeau EB, Sakhrani D, Biagi CA, Johnson H, Joshi J, Flores AM, Leelakumari S, Moore R, Pandoh PK, Withler RE, Beacham TD, Leggatt RA, Tarpey CM, Seeb LW, Seeb JE, Jones SJM, Devlin RH, Koop BF. The pink salmon genome: Uncovering the genomic consequences of a two-year life cycle. PLoS One. 2021 Dec 17;16(12):e0255752. doi: 10.1371/journal.pone.0255752. eCollection 2021. PMID: 34919547.
Copy Download .nbib Format: NLM
Correlations Between Facial Expressivity and Apathy in Elderly People With Neurocognitive Disorders: Exploratory Study.

JMIR formative research

Zeghari R, König A, Guerchouche R, Sharma G, Joshi J, Fabre R, Robert P, Manera V.
PMID: 33787499
JMIR Form Res. 2021 Mar 31;5(3):e24727. doi: 10.2196/24727.

BACKGROUND: Neurocognitive disorders are often accompanied by behavioral symptoms such as anxiety, depression, and/or apathy. These symptoms can occur very early in the disease progression and are often difficult to detect and quantify in nonspecialized clinical settings.OBJECTIVE: We focus...

Cite
Zeghari R, König A, Guerchouche R, et al. Correlations Between Facial Expressivity and Apathy in Elderly People With Neurocognitive Disorders: Exploratory Study. JMIR Form Res. 2021;5(3):e24727doi: 10.2196/24727.
Zeghari, R., König, A., Guerchouche, R., Sharma, G., Joshi, J., Fabre, R., Robert, P., & Manera, V. (2021). Correlations Between Facial Expressivity and Apathy in Elderly People With Neurocognitive Disorders: Exploratory Study. JMIR formative research, 5(3), e24727. https://doi.org/10.2196/24727
Zeghari, Radia, et al. "Correlations Between Facial Expressivity and Apathy in Elderly People With Neurocognitive Disorders: Exploratory Study." JMIR formative research vol. 5,3 (2021): e24727. doi: https://doi.org/10.2196/24727
Zeghari R, König A, Guerchouche R, Sharma G, Joshi J, Fabre R, Robert P, Manera V. Correlations Between Facial Expressivity and Apathy in Elderly People With Neurocognitive Disorders: Exploratory Study. JMIR Form Res. 2021 Mar 31;5(3):e24727. doi: 10.2196/24727. PMID: 33787499; PMCID: PMC8047819.
Copy Download .nbib Format: NLM
Safety and Efficacy of Botulinum Toxin in the Treatment of Self-Biting Behavior in Lesch-Nyhan Disease.

Pediatric neurology

Garcia-Romero MDM, Torres RJ, Garcia-Puig J, Pascual-Pascual SI.
PMID: 34891105
Pediatr Neurol. 2021 Nov 01;127:6-10. doi: 10.1016/j.pediatrneurol.2021.10.018. Epub 2021 Nov 01.

BACKGROUND: Lesch-Nyhan disease (LND) is a disease of purine metabolism linked to chromosome X due to the absence or near-absence of enzyme hypoxanthine-guanine phosphoribosyltransferase. Patients with LND have a compulsive autoaggressive behavior that consists of self-mutilation by biting.METHODS: The...

Cite
Garcia-Romero MDM, Torres RJ, Garcia-Puig J, et al. Safety and Efficacy of Botulinum Toxin in the Treatment of Self-Biting Behavior in Lesch-Nyhan Disease. Pediatr Neurol. 2021;127:6-10doi: 10.1016/j.pediatrneurol.2021.10.018.
Garcia-Romero, M. D. M., Torres, R. J., Garcia-Puig, J., & Pascual-Pascual, S. I. (2021). Safety and Efficacy of Botulinum Toxin in the Treatment of Self-Biting Behavior in Lesch-Nyhan Disease. Pediatric neurology, 1276-10. https://doi.org/10.1016/j.pediatrneurol.2021.10.018
Garcia-Romero, María Del Mar, et al. "Safety and Efficacy of Botulinum Toxin in the Treatment of Self-Biting Behavior in Lesch-Nyhan Disease." Pediatric neurology vol. 127 (2021): 6-10. doi: https://doi.org/10.1016/j.pediatrneurol.2021.10.018
Garcia-Romero MDM, Torres RJ, Garcia-Puig J, Pascual-Pascual SI. Safety and Efficacy of Botulinum Toxin in the Treatment of Self-Biting Behavior in Lesch-Nyhan Disease. Pediatr Neurol. 2021 Nov 01;127:6-10. doi: 10.1016/j.pediatrneurol.2021.10.018. Epub 2021 Nov 01. PMID: 34891105.
Copy Download .nbib Format: NLM
Apple Watch® facilitates single-session catheter ablation of coexisting atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia.

Clinical case reports

Kasai Y, Kasai J, Sekiguchi Y, Asano S, Fukunaga H, Nagase T, Nitta J.
PMID: 34457301
Clin Case Rep. 2021 Aug 21;9(8):e04702. doi: 10.1002/ccr3.4702. eCollection 2021 Aug.

Heart rate information from a smartwatch can facilitate the diagnosis and treatment of SVT. Benefitting from long-term HR trends, we performed successful RF catheter ablation of coexisting AVNRT and AVRT.

Cite
Kasai Y, Kasai J, Sekiguchi Y, et al. Apple Watch® facilitates single-session catheter ablation of coexisting atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia. Clin Case Rep. 2021;9(8):e04702doi: 10.1002/ccr3.4702.
Kasai, Y., Kasai, J., Sekiguchi, Y., Asano, S., Fukunaga, H., Nagase, T., & Nitta, J. (2021). Apple Watch® facilitates single-session catheter ablation of coexisting atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia. Clinical case reports, 9(8), e04702. https://doi.org/10.1002/ccr3.4702
Kasai, Yuhei, et al. "Apple Watch® facilitates single-session catheter ablation of coexisting atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia." Clinical case reports vol. 9,8 (2021): e04702. doi: https://doi.org/10.1002/ccr3.4702
Kasai Y, Kasai J, Sekiguchi Y, Asano S, Fukunaga H, Nagase T, Nitta J. Apple Watch® facilitates single-session catheter ablation of coexisting atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia. Clin Case Rep. 2021 Aug 21;9(8):e04702. doi: 10.1002/ccr3.4702. eCollection 2021 Aug. PMID: 34457301; PMCID: PMC8380080.
Copy Download .nbib Format: NLM
Showing 529 to 537 of 537 entries